Ruby 4.0: A lot of restructuring under the hood, few new features

The new major version with a new JIT compiler, a revised parallelization API, and a maturing type system paves the way for ...
pharmaphorum

Recursion, Exscientia, and AI drug discovery’s moment of truth

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
pharmaphorum

Company Profile: Recursion

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
TwistedSifter on MSN

Forum member tried helping a gamer diagnose a crash, but the game denied anything was wrong at every step and made it impossible to troubleshoot

Know More 3 Forum Member Tried Helping A Gamer Diagnose A Crash, But The Game Denied Anything Was Wrong At Every Step And ...